Skip to content
DraconiticResearch
Search Sources API
182,469 studies31 sourcesUpdated 14 min ago
PreprintAll rights reservedbioRxiv

Targeting TMPRSS2-ERG Fusion-Driven Prostate Cancer using Novel HBS-α-Helicomimics

  1. 1Indian Institute of Technology Kanpur

Related

  1. Pharmacologic Targeting of ZNF281 Suppresses Metastatic Prostate Cancer Beyond Androgen Receptor Dependence
    G. Huang, M. A. Lorenzana Carrillo, H. Chen +14
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  2. Box C/D SNORD116-17 promotes prostate cancer progression by targeting the miR-206/E2F5 axis
    Xiuyi Pan, Yifan Kang, Jinjing Zhong +9
    iSciencePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationOncologyCell PressCrossrefEurope PMC
  3. Cognitive fusion targeted biopsy is not inferior to systematic biopsy in metastatic prostate cancer: a single-center, paired study
    Yonghai Chen, Xingli Shan, Linjun Hu +5
    BMC UrologyPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  4. Design and Preclinical Evaluation of Two Prostate-Specific Membrane Antigen-Targeting Trifluoroborate Derivatives Suitable for One-Step Radiofluorination
    Andreas Paulus, Sofia Otaru, Risto Savela +11
    ACS OmegaPeer-reviewedCC BY 4.0Full textMedical imaging & radiologyCrossref
  5. Prospective Comparison of Cognitive MRI-Targeted Biopsy Under Micro-Ultrasound Guidance Versus MRI/Ultrasound Fusion-Guided Transperineal Biopsy for Clinically Significant Prostate Cancer Detection
    Agostino Fraia, Sara Riolo, Francesco Di Bello +13
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMCCrossref
BibTeX
@misc{kundu2026targeting,
  title = {{Targeting TMPRSS2-ERG Fusion-Driven Prostate Cancer using Novel HBS-α-Helicomimics}},
  author = {S. Kundu and P. Ganguly and L. Varte and S. Mahajan and E. N. Prabhakaran and B. Ateeq},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.14.759088},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.14.759088v1},
}
RIS
TY  - UNPB
TI  - Targeting TMPRSS2-ERG Fusion-Driven Prostate Cancer using Novel HBS-α-Helicomimics
AU  - S. Kundu
AU  - P. Ganguly
AU  - L. Varte
AU  - S. Mahajan
AU  - E. N. Prabhakaran
AU  - B. Ateeq
PY  - 2026
DA  - 2026/10/14
PB  - bioRxiv
DO  - 10.64898/2026.10.14.759088
UR  - https://www.biorxiv.org/content/10.64898/2026.10.14.759088v1
ER  -